Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE (TCM)

Tongjitang Chinese Medicines Company TCM, announced today the completion of its acquisition by Hanmax Investment Limited, a British Virgin Islands business company, and Fosun Industrial Co., Limited, a company incorporated in Hong Kong. As a result of the acquisition, the Company became a wholly owned subsidiary of Hanmax and Fosun. Hanmax is an affiliate of Mr. Xiaochun Wang, chairman of the board of directors and chief executive officer of the Company.